Anti-angiogenic effects of lycopene through immunomodualtion of cytokine secretion in human peripheral blood mononuclear cells

Journal of Nutritional Biochemistry

Volumn 24, Issue 2, 2013, Pages 428-434

  Huang, Chin Shiu ^a   Chuang, Cheng Hung ^b   Lo, Tsue Feng ^a   Hu, Miao Lin ^c  

^a ASIA UNIVERSITY   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Immunomodulation; Interleukin 12; Lycopene; Mononuclear cells

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 17; LYCOPENE;

ADULT; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

ADULT; ANGIOGENESIS INHIBITORS; ANIMALS; CAROTENOIDS; CELL MOVEMENT; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CULTURE MEDIA, CONDITIONED; CYTOKINES; DEXAMETHASONE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MATRIX METALLOPROTEINASE 2; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84872761474     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.01.003     Document Type: Article

References (49)

1. Folkman J. Angiogenesis. Annu Rev Med 2006, 57:1-18.
2. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
3. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 1990, 82:4-6.
4. Zhou J.R., Yu L., Zhong Y., Blackburn G.L. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr 2003, 133:516-521.
5. Fox S.B. Tumour angiogenesis and prognosis. Histopathology 1997, 30:294-301.
6. Coleman K.R., Braden G.A., Willingham M.C., Sane D.C. Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (alphavbeta3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits. Circ Res 1999, 84:1268-1276.
7. Sogno I., Venè R., Ferrari N., De Censi A., Imperatori A., Noonan D.M., et al. Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies. Crit Rev Oncol Hematol 2010, 75:2-14.
8. Tsuzuki T., Shibata A., Kawakami Y., Nakagawa K., Miyazawa T. Conjugated eicosapentaenoic acid inhibits vascular endothelial growth factor-induced angiogenesis by suppressing the migration of human umbilical vein endothelial cells. J Nutr 2007, 137:641-646.
9. Harada N., Shimada M., Okano S., Suehiro T., Soejima Y., Tomita Y., et al. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice. J Immunol 2004, 173:6635-6644.
10. Sgadari C., Angiolillo A.L., Tosato G. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 1996, 87:3877-3882.
11. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801.
12. Li A., Dubey S., Varney M.L., Dave B.J., Singh R.K. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003, 170:3369-3376.
13. Ferrara N., Kerbel R.S. Angiogenesis as a therapeutic target. Nature 2005, 438:967-974.
14. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
15. Tang Y., Nakada M.T., Kesavan P., McCabe F., Millar H., Rafferty P., et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 2005, 65:3193-3199.
16. Oh J., Takahashi R., Kondo S., Mizoguchi A., Adachi E., Sasahara R.M., et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001, 107:789-800.
17. Brunda M.J., Luistro L., Warrier R.R., Wright R.B., Hubbard B.R., Murphy M., et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993, 178:1223-1230.
18. Dias S., Thomas H., Balkwill F. Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model. Int J Cancer 1998, 75:151-157.
19. Li A., Varney M.L., Valasek J., Godfrey M., Dave B.J., Singh R.K. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 2005, 8:63-71.
20. Dias S., Boyd R., Balkwill F. IL-12 regulates VEGF and MMPs in a murine breast cancer model. Int J Cancer 1998, 78:361-365.
21. Ferrara N. VEGF as a therapeutic target in cancer. Oncology 2005, 69:11-16.
22. Murray G.I., Duncan M.E., O'Neil P., Melvin W.T., Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996, 2:461-462.
23. Chambers A.F., Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997, 89:1260-1270.
24. Matrisian L.M., Wright J., Newell K., Witty J.P. Matrix-degrading metalloproteinases in tumor progression. Princess Takamatsu Symp 1994, 24:152-161.
25. Nilsson U.W., Dabrosin C. Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo. Cancer Res 2006, 66:4789-4794.
26. Bendich A., Olson J.A. Biological actions of carotenoids. FASEB J 1989, 3:1927-1932.
27. Chew B.P., Park J.S. Carotenoid action on the immune response. J Nutr 2004, 134:257-261.
28. Kim G.Y., Kim J.H., Ahn S.C., Lee H.J., Moon D.O., Lee C.M., et al. Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB. Immunology 2004, 113:203-211.
29. Bessler H., Salman H., Bergman M., Alcalay Y., Djaldetti M. In vitro effect of lycopene on cytokine production by human peripheral blood mononuclear cells. Immunol Invest 2008, 37:183-190.
30. Li B.H., Zhang Q.X., Dong D.J., Lin X.M. Effect of lycopene on immunity in rats with acute lung injury. Beijing Da Xue Xue Bao 2007, 39:77-82.
31. Luo C., Wu X.G. Lycopene enhances antioxidant enzyme activities and immunity function in N-Methyl-N'-nitro-N-nitrosoguanidine-induced gastric cancer rats. Int J Mol Sci 2011, 12:3340-3351.
32. Neyestani T.R., Shariatzadeh N., Gharavi A., Kalayi A., Khalaji N. Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with Type 2 diabetes mellitus: a possible role in the prevention of long-term complications. J Endocrinol Invest 2007, 30:833-838.
33. Watzl B., Bub A., Blockhaus M., Herbert B.M., Luhrmann P.M., Neuhauser-Berthold M., et al. Prolonged tomato juice consumption has no effect on cell-mediated immunity of well-nourished elderly men and women. J Nutr 2000, 130:1719-1723.
34. Sahin M., Sahin E., Gümüşlü S. Effects of lycopene and apigenin on human umbilical vein endothelial cells in vitro under angiogenic stimulation. Acta Histochem 2012, 114:94-100.
35. Huang C.S., Liao J.W., Hu M.L. Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. J Nutr 2008, 138:538-543.
36. Chen Y.J., Shiao M.S., Lee S.S., Wang S.Y. Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells. Life Sci 1997, 60:2349-2359.
37. Ma W., Gee K., Lim W., Chambers K., Angel J.B., Kozlowski M., et al. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors. J Immunol 2004, 172:318-330.
38. Repesh L.A. A new in vitro assay for quantitating tumor cell invasion. Invas Metast 1989, 9:192-208.
39. Huang C.S., Fan Y.E., Lin C.Y., Hu M.L. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. J Nutr Biochem 2007, 18:449-456.
40. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A.B., et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006, 66:7843-7848.
41. Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol 2002, 23:144-150.
42. Watzl B., Bub A., Brandstetter B.R., Rechkemmer G. Modulation of human T-lymphocyte functions by the consumption of carotenoid-rich vegetables. Br J Nutr 1999, 82:383-389.
43. Trinchieri G., Scott P. Interleukin-12: basic principles and clinical applications. Curr Top Microbiol Immunol 1999, 238:57-78.
44. Simonini A., Moscucci M., Muller D.W., Bates E.R., Pagani F.D., Burdick M.D., et al. IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation 2000, 101:1519-1526.
45. Ribatti D., Nico B., Pezzolo A., Vacca A., Meazza R., Cinti R., Carlini B., Parodi F., Pistoia V., Corrias M.V. Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma. Br J Cancer 2006, 94:1845-1852.
46. Wysoczynski M., Shin D.M., Kucia M., Ratajczak M.Z. Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications. Int J Cancer 2010, 126:371-381.
47. Simone R.E., Russo M., Catalano A., Monego G., Froehlich K., Boehm V., Palozza P. Lycopene inhibits NF-kB-mediated IL-8 expression and changes redox and PPARγ signalling in cigarette smoke-stimulated macrophages. PLoS One 2011, e19652:6.
48. Tamura K., Sakurai T., Kogo H. Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells. Vascul Pharmacol 2006, 44:411-416.
49. Wang D., Dubois R.N. Prostaglandins and cancer. Gut 2006, 55:115-122.